BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 26912360)

  • 21. Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (
    Bou Zerdan M; Ashok Kumar P; Haroun E; Srivastava N; Ross J; Sivapiragasam A
    Oncotarget; 2023 Mar; 14():178-187. PubMed ID: 36913304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulation of protein methylation in melanoma.
    Limm K; Ott C; Wallner S; Mueller DW; Oefner P; Hellerbrand C; Bosserhoff AK
    Eur J Cancer; 2013 Apr; 49(6):1305-13. PubMed ID: 23265702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP-deficient lung cancer.
    Chang WH; Chen YJ; Hsiao YJ; Chiang CC; Wang CY; Chang YL; Hong QS; Lin CY; Lin SU; Chang GC; Chen HY; Chen YJ; Chen CH; Yang PC; Yu SL
    EMBO Rep; 2022 Aug; 23(8):e54265. PubMed ID: 35766227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition state analogue of MTAP extends lifespan of APC
    Firestone RS; Feng M; Basu I; Peregrina K; Augenlicht LH; Schramm VL
    Sci Rep; 2021 Apr; 11(1):8844. PubMed ID: 33893330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
    Lubin M; Lubin A
    PLoS One; 2009 May; 4(5):e5735. PubMed ID: 19478948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation.
    Jacobs B; Schlögl S; Strobl CD; Völkl S; Stoll A; Mougiakakos D; Malmberg KJ; Mackensen A; Aigner M
    Front Immunol; 2020; 11():2128. PubMed ID: 33123121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.
    Basu I; Locker J; Cassera MB; Belbin TJ; Merino EF; Dong X; Hemeon I; Evans GB; Guha C; Schramm VL
    J Biol Chem; 2011 Feb; 286(6):4902-11. PubMed ID: 21135097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.
    Engstrom LD; Aranda R; Waters L; Moya K; Bowcut V; Vegar L; Trinh D; Hebbert A; Smith CR; Kulyk S; Lawson JD; He L; Hover LD; Fernandez-Banet J; Hallin J; Vanderpool D; Briere DM; Blaj A; Marx MA; Rodon J; Offin M; Arbour KC; Johnson ML; Kwiatkowski DJ; Jänne PA; Haddox CL; Papadopoulos KP; Henry JT; Leventakos K; Christensen JG; Shazer R; Olson P
    Cancer Discov; 2023 Nov; 13(11):2412-2431. PubMed ID: 37552839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
    Chen ZH; Zhang H; Savarese TM
    Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.
    Batova A; Cottam H; Yu J; Diccianni MB; Carrera CJ; Yu AL
    Blood; 2006 Feb; 107(3):898-903. PubMed ID: 16234352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease.
    Bigaud E; Corrales FJ
    Mol Cell Proteomics; 2016 May; 15(5):1498-510. PubMed ID: 26819315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity.
    Gordon RB; Blackwell K; Emmerson BT
    Biochim Biophys Acta; 1987 Jan; 927(1):1-7. PubMed ID: 3098299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry.
    Stevens AP; Dettmer K; Wallner S; Bosserhoff AK; Oefner PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):123-8. PubMed ID: 18996776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers.
    Karikari CA; Mullendore M; Eshleman JR; Argani P; Leoni LM; Chattopadhyay S; Hidalgo M; Maitra A
    Mol Cancer Ther; 2005 Dec; 4(12):1860-6. PubMed ID: 16373701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
    Christopher SA; Diegelman P; Porter CW; Kruger WD
    Cancer Res; 2002 Nov; 62(22):6639-44. PubMed ID: 12438261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
    Dominici C; Sgarioto N; Yu Z; Sesma-Sanz L; Masson JY; Richard S; Raynal NJ
    Clin Epigenetics; 2021 Mar; 13(1):54. PubMed ID: 33691794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamic analysis of transition-state features in picomolar inhibitors of human 5'-methylthioadenosine phosphorylase.
    Guan R; Tyler PC; Evans GB; Schramm VL
    Biochemistry; 2013 Nov; 52(46):8313-22. PubMed ID: 24148083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
    Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
    Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.